0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Atrial Septal Occluder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-29K12235
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Atrial Septal Occluder Market Research Report 2022
BUY CHAPTERS

Atrial Septal Occluder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-29K12235
Report
December 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Atrial Septal Occluder - Market Size

The global market for Atrial Septal Occluder was estimated to be worth US$ 930 million in 2023 and is forecast to a readjusted size of US$ 1283.6 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030

Atrial Septal Occluder - Market

Atrial Septal Occluder - Market

An atrial septal occluder is a medical device used to close an atrial septal defect (ASD), which is a hole in the wall (septum) that separates the two upper chambers (atria) of the heart. This device is a treatment option for individuals with ASD who require closure to prevent blood flow between the atria and improve heart function.
The global atrial septal occluder market refers to the market for devices used in the closure of atrial septal defects (ASDs), which are congenital heart defects involving a hole in the wall (septum) separating the two upper chambers of the heart (atria). Atrial septal occluders are implantable devices designed to close these holes and restore normal blood flow within the heart.
The market for atrial septal occluders is driven by several factors. Firstly, the rising prevalence of ASDs globally contributes to the demand for effective closure devices. Improved diagnostics techniques and increased awareness of congenital heart defects have led to earlier identification and intervention, allowing for better management of ASDs.
Secondly, advancements in medical technologies and surgical techniques have significantly improved the treatment and outcomes for individuals with ASDs. Atrial septal occluders provide a minimally invasive alternative to traditional open-heart surgeries, resulting in shorter hospital stays, faster recovery times, and reduced overall healthcare costs. These factors have contributed to the increasing adoption of atrial septal occluders as the preferred treatment option for ASD closure.
Furthermore, the growing focus on patient-centric approaches and personalized medicine has led to the development of innovative and improved atrial septal occluder designs. These devices offer better procedural outcomes, reduced risk of complications, and enhanced patient comfort. Additionally, ongoing research is focused on optimizing device size, improving closure efficacy, and reducing long-term complications associated with atrial septal occluders.
Geographically, North America, Europe, and Asia-Pacific are the prominent markets for atrial septal occluders. These regions have well-established healthcare systems, advanced cardiac care facilities, and higher prevalence of ASD cases. Increased access to healthcare services, favorable reimbursement policies, and the presence of key market players contribute to the overall market growth.
Key players in the global atrial septal occluder market include medical device manufacturers, interventional cardiology companies, and healthcare providers. These companies are engaged in the development, manufacturing, and commercialization of atrial septal occluders, as well as providing procedural training and support to healthcare professionals.
In conclusion, the global atrial septal occluder market is driven by the rising prevalence of ASDs, advancements in medical technologies and surgical techniques, and the growing focus on patient-centered approaches. Atrial septal occluders offer a minimally invasive treatment option with improved procedural outcomes, reduced complications, and faster recovery times. With the increasing adoption of atrial septal occluders as the preferred treatment choice, the market is expected to witness significant growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Atrial Septal Occluder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atrial Septal Occluder by region & country, by Type, and by Application.
The Atrial Septal Occluder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrial Septal Occluder.
Market Segmentation

Scope of Atrial Septal Occluder - Market Report

Report Metric Details
Report Name Atrial Septal Occluder - Market
Forecasted market size in 2030 US$ 1283.6 million
CAGR 4.6%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Medtronic Plc, Endologix Inc, LivaNova Plc, CryoLife Inc, Cook Group Incorporated, Edwards Lifesciences Corporation, W. L. Gore & Associates, Lepu Medical Technology, CeraFlex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Atrial Septal Occluder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Atrial Septal Occluder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Atrial Septal Occluder in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Atrial Septal Occluder - Market size in 2030?

Ans: The Atrial Septal Occluder - Market size in 2030 will be US$ 1283.6 million.

Who are the main players in the Atrial Septal Occluder - Market report?

Ans: The main players in the Atrial Septal Occluder - Market are Abbott Laboratories, Medtronic Plc, Endologix Inc, LivaNova Plc, CryoLife Inc, Cook Group Incorporated, Edwards Lifesciences Corporation, W. L. Gore & Associates, Lepu Medical Technology, CeraFlex

What are the Application segmentation covered in the Atrial Septal Occluder - Market report?

Ans: The Applications covered in the Atrial Septal Occluder - Market report are Hospital, Outpatient Surgery Center, Specialty Clinics

What are the Type segmentation covered in the Atrial Septal Occluder - Market report?

Ans: The Types covered in the Atrial Septal Occluder - Market report are Atrial Septal Defect Device, Ventricular Septal Defect Device

Recommended Reports

Occluder Devices

Heart Closure Devices

Catheters & Adjuncts

1 Market Overview
1.1 Atrial Septal Occluder Product Introduction
1.2 Global Atrial Septal Occluder Market Size Forecast
1.2.1 Global Atrial Septal Occluder Sales Value (2019-2030)
1.2.2 Global Atrial Septal Occluder Sales Volume (2019-2030)
1.2.3 Global Atrial Septal Occluder Sales Price (2019-2030)
1.3 Atrial Septal Occluder Market Trends & Drivers
1.3.1 Atrial Septal Occluder Industry Trends
1.3.2 Atrial Septal Occluder Market Drivers & Opportunity
1.3.3 Atrial Septal Occluder Market Challenges
1.3.4 Atrial Septal Occluder Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Atrial Septal Occluder Players Revenue Ranking (2023)
2.2 Global Atrial Septal Occluder Revenue by Company (2019-2024)
2.3 Global Atrial Septal Occluder Players Sales Volume Ranking (2023)
2.4 Global Atrial Septal Occluder Sales Volume by Company Players (2019-2024)
2.5 Global Atrial Septal Occluder Average Price by Company (2019-2024)
2.6 Key Manufacturers Atrial Septal Occluder Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Atrial Septal Occluder Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Atrial Septal Occluder
2.9 Atrial Septal Occluder Market Competitive Analysis
2.9.1 Atrial Septal Occluder Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Atrial Septal Occluder Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrial Septal Occluder as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Atrial Septal Defect Device
3.1.2 Ventricular Septal Defect Device
3.2 Global Atrial Septal Occluder Sales Value by Type
3.2.1 Global Atrial Septal Occluder Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Atrial Septal Occluder Sales Value, by Type (2019-2030)
3.2.3 Global Atrial Septal Occluder Sales Value, by Type (%) (2019-2030)
3.3 Global Atrial Septal Occluder Sales Volume by Type
3.3.1 Global Atrial Septal Occluder Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Atrial Septal Occluder Sales Volume, by Type (2019-2030)
3.3.3 Global Atrial Septal Occluder Sales Volume, by Type (%) (2019-2030)
3.4 Global Atrial Septal Occluder Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Outpatient Surgery Center
4.1.3 Specialty Clinics
4.2 Global Atrial Septal Occluder Sales Value by Application
4.2.1 Global Atrial Septal Occluder Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Atrial Septal Occluder Sales Value, by Application (2019-2030)
4.2.3 Global Atrial Septal Occluder Sales Value, by Application (%) (2019-2030)
4.3 Global Atrial Septal Occluder Sales Volume by Application
4.3.1 Global Atrial Septal Occluder Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Atrial Septal Occluder Sales Volume, by Application (2019-2030)
4.3.3 Global Atrial Septal Occluder Sales Volume, by Application (%) (2019-2030)
4.4 Global Atrial Septal Occluder Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Atrial Septal Occluder Sales Value by Region
5.1.1 Global Atrial Septal Occluder Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Atrial Septal Occluder Sales Value by Region (2019-2024)
5.1.3 Global Atrial Septal Occluder Sales Value by Region (2025-2030)
5.1.4 Global Atrial Septal Occluder Sales Value by Region (%), (2019-2030)
5.2 Global Atrial Septal Occluder Sales Volume by Region
5.2.1 Global Atrial Septal Occluder Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Atrial Septal Occluder Sales Volume by Region (2019-2024)
5.2.3 Global Atrial Septal Occluder Sales Volume by Region (2025-2030)
5.2.4 Global Atrial Septal Occluder Sales Volume by Region (%), (2019-2030)
5.3 Global Atrial Septal Occluder Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Atrial Septal Occluder Sales Value, 2019-2030
5.4.2 North America Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Atrial Septal Occluder Sales Value, 2019-2030
5.5.2 Europe Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Atrial Septal Occluder Sales Value, 2019-2030
5.6.2 Asia Pacific Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Atrial Septal Occluder Sales Value, 2019-2030
5.7.2 South America Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Atrial Septal Occluder Sales Value, 2019-2030
5.8.2 Middle East & Africa Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Atrial Septal Occluder Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Atrial Septal Occluder Sales Value
6.2.1 Key Countries/Regions Atrial Septal Occluder Sales Value, 2019-2030
6.2.2 Key Countries/Regions Atrial Septal Occluder Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Atrial Septal Occluder Sales Value, 2019-2030
6.3.2 United States Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Atrial Septal Occluder Sales Value, 2019-2030
6.4.2 Europe Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Atrial Septal Occluder Sales Value, 2019-2030
6.5.2 China Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.5.3 China Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Atrial Septal Occluder Sales Value, 2019-2030
6.6.2 Japan Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Atrial Septal Occluder Sales Value, 2019-2030
6.7.2 South Korea Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Atrial Septal Occluder Sales Value, 2019-2030
6.8.2 Southeast Asia Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Atrial Septal Occluder Sales Value, 2019-2030
6.9.2 India Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
6.9.3 India Atrial Septal Occluder Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Information
7.1.2 Abbott Laboratories Introduction and Business Overview
7.1.3 Abbott Laboratories Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Laboratories Atrial Septal Occluder Product Offerings
7.1.5 Abbott Laboratories Recent Development
7.2 Medtronic Plc
7.2.1 Medtronic Plc Company Information
7.2.2 Medtronic Plc Introduction and Business Overview
7.2.3 Medtronic Plc Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Plc Atrial Septal Occluder Product Offerings
7.2.5 Medtronic Plc Recent Development
7.3 Endologix Inc
7.3.1 Endologix Inc Company Information
7.3.2 Endologix Inc Introduction and Business Overview
7.3.3 Endologix Inc Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Endologix Inc Atrial Septal Occluder Product Offerings
7.3.5 Endologix Inc Recent Development
7.4 LivaNova Plc
7.4.1 LivaNova Plc Company Information
7.4.2 LivaNova Plc Introduction and Business Overview
7.4.3 LivaNova Plc Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.4.4 LivaNova Plc Atrial Septal Occluder Product Offerings
7.4.5 LivaNova Plc Recent Development
7.5 CryoLife Inc
7.5.1 CryoLife Inc Company Information
7.5.2 CryoLife Inc Introduction and Business Overview
7.5.3 CryoLife Inc Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CryoLife Inc Atrial Septal Occluder Product Offerings
7.5.5 CryoLife Inc Recent Development
7.6 Cook Group Incorporated
7.6.1 Cook Group Incorporated Company Information
7.6.2 Cook Group Incorporated Introduction and Business Overview
7.6.3 Cook Group Incorporated Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cook Group Incorporated Atrial Septal Occluder Product Offerings
7.6.5 Cook Group Incorporated Recent Development
7.7 Edwards Lifesciences Corporation
7.7.1 Edwards Lifesciences Corporation Company Information
7.7.2 Edwards Lifesciences Corporation Introduction and Business Overview
7.7.3 Edwards Lifesciences Corporation Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Edwards Lifesciences Corporation Atrial Septal Occluder Product Offerings
7.7.5 Edwards Lifesciences Corporation Recent Development
7.8 W. L. Gore & Associates
7.8.1 W. L. Gore & Associates Company Information
7.8.2 W. L. Gore & Associates Introduction and Business Overview
7.8.3 W. L. Gore & Associates Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.8.4 W. L. Gore & Associates Atrial Septal Occluder Product Offerings
7.8.5 W. L. Gore & Associates Recent Development
7.9 Lepu Medical Technology
7.9.1 Lepu Medical Technology Company Information
7.9.2 Lepu Medical Technology Introduction and Business Overview
7.9.3 Lepu Medical Technology Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Lepu Medical Technology Atrial Septal Occluder Product Offerings
7.9.5 Lepu Medical Technology Recent Development
7.10 CeraFlex
7.10.1 CeraFlex Company Information
7.10.2 CeraFlex Introduction and Business Overview
7.10.3 CeraFlex Atrial Septal Occluder Sales, Revenue and Gross Margin (2019-2024)
7.10.4 CeraFlex Atrial Septal Occluder Product Offerings
7.10.5 CeraFlex Recent Development
8 Industry Chain Analysis
8.1 Atrial Septal Occluder Industrial Chain
8.2 Atrial Septal Occluder Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Atrial Septal Occluder Sales Model
8.5.2 Sales Channel
8.5.3 Atrial Septal Occluder Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Atrial Septal Occluder Market Trends
    Table 2. Atrial Septal Occluder Market Drivers & Opportunity
    Table 3. Atrial Septal Occluder Market Challenges
    Table 4. Atrial Septal Occluder Market Restraints
    Table 5. Global Atrial Septal Occluder Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Atrial Septal Occluder Revenue Market Share by Company (2019-2024)
    Table 7. Global Atrial Septal Occluder Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Atrial Septal Occluder Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Atrial Septal Occluder Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Atrial Septal Occluder Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Atrial Septal Occluder Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Atrial Septal Occluder
    Table 13. Global Atrial Septal Occluder Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrial Septal Occluder as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Atrial Septal Occluder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Atrial Septal Occluder Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Atrial Septal Occluder Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Atrial Septal Occluder Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Atrial Septal Occluder Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Atrial Septal Occluder Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Atrial Septal Occluder Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Atrial Septal Occluder Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Atrial Septal Occluder Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Atrial Septal Occluder Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Atrial Septal Occluder Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Atrial Septal Occluder Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Atrial Septal Occluder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Atrial Septal Occluder Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Atrial Septal Occluder Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Atrial Septal Occluder Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Atrial Septal Occluder Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Atrial Septal Occluder Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Atrial Septal Occluder Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Atrial Septal Occluder Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Atrial Septal Occluder Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Atrial Septal Occluder Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Atrial Septal Occluder Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Atrial Septal Occluder Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Atrial Septal Occluder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Atrial Septal Occluder Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Atrial Septal Occluder Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Atrial Septal Occluder Sales Value by Region (2019-2024) & (%)
    Table 44. Global Atrial Septal Occluder Sales Value by Region (2025-2030) & (%)
    Table 45. Global Atrial Septal Occluder Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Atrial Septal Occluder Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Atrial Septal Occluder Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Atrial Septal Occluder Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Atrial Septal Occluder Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Atrial Septal Occluder Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Atrial Septal Occluder Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Atrial Septal Occluder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Atrial Septal Occluder Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Atrial Septal Occluder Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Atrial Septal Occluder Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Atrial Septal Occluder Sales Volume, (2025-2030) & (K Units)
    Table 57. Abbott Laboratories Company Information
    Table 58. Abbott Laboratories Introduction and Business Overview
    Table 59. Abbott Laboratories Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Abbott Laboratories Atrial Septal Occluder Product Offerings
    Table 61. Abbott Laboratories Recent Development
    Table 62. Medtronic Plc Company Information
    Table 63. Medtronic Plc Introduction and Business Overview
    Table 64. Medtronic Plc Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Medtronic Plc Atrial Septal Occluder Product Offerings
    Table 66. Medtronic Plc Recent Development
    Table 67. Endologix Inc Company Information
    Table 68. Endologix Inc Introduction and Business Overview
    Table 69. Endologix Inc Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Endologix Inc Atrial Septal Occluder Product Offerings
    Table 71. Endologix Inc Recent Development
    Table 72. LivaNova Plc Company Information
    Table 73. LivaNova Plc Introduction and Business Overview
    Table 74. LivaNova Plc Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. LivaNova Plc Atrial Septal Occluder Product Offerings
    Table 76. LivaNova Plc Recent Development
    Table 77. CryoLife Inc Company Information
    Table 78. CryoLife Inc Introduction and Business Overview
    Table 79. CryoLife Inc Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. CryoLife Inc Atrial Septal Occluder Product Offerings
    Table 81. CryoLife Inc Recent Development
    Table 82. Cook Group Incorporated Company Information
    Table 83. Cook Group Incorporated Introduction and Business Overview
    Table 84. Cook Group Incorporated Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Cook Group Incorporated Atrial Septal Occluder Product Offerings
    Table 86. Cook Group Incorporated Recent Development
    Table 87. Edwards Lifesciences Corporation Company Information
    Table 88. Edwards Lifesciences Corporation Introduction and Business Overview
    Table 89. Edwards Lifesciences Corporation Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Edwards Lifesciences Corporation Atrial Septal Occluder Product Offerings
    Table 91. Edwards Lifesciences Corporation Recent Development
    Table 92. W. L. Gore & Associates Company Information
    Table 93. W. L. Gore & Associates Introduction and Business Overview
    Table 94. W. L. Gore & Associates Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. W. L. Gore & Associates Atrial Septal Occluder Product Offerings
    Table 96. W. L. Gore & Associates Recent Development
    Table 97. Lepu Medical Technology Company Information
    Table 98. Lepu Medical Technology Introduction and Business Overview
    Table 99. Lepu Medical Technology Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Lepu Medical Technology Atrial Septal Occluder Product Offerings
    Table 101. Lepu Medical Technology Recent Development
    Table 102. CeraFlex Company Information
    Table 103. CeraFlex Introduction and Business Overview
    Table 104. CeraFlex Atrial Septal Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. CeraFlex Atrial Septal Occluder Product Offerings
    Table 106. CeraFlex Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Atrial Septal Occluder Downstream Customers
    Table 110. Atrial Septal Occluder Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Atrial Septal Occluder Product Picture
    Figure 2. Global Atrial Septal Occluder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Atrial Septal Occluder Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Atrial Septal Occluder Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Atrial Septal Occluder Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Atrial Septal Occluder Report Years Considered
    Figure 7. Global Atrial Septal Occluder Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Atrial Septal Occluder Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Atrial Septal Occluder Revenue in 2023
    Figure 10. Atrial Septal Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Atrial Septal Defect Device Picture
    Figure 12. Ventricular Septal Defect Device Picture
    Figure 13. Global Atrial Septal Occluder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Atrial Septal Occluder Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Atrial Septal Occluder Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Atrial Septal Occluder Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Atrial Septal Occluder Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Outpatient Surgery Center
    Figure 20. Product Picture of Specialty Clinics
    Figure 21. Global Atrial Septal Occluder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Atrial Septal Occluder Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Atrial Septal Occluder Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Atrial Septal Occluder Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Atrial Septal Occluder Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Atrial Septal Occluder Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Atrial Septal Occluder Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Atrial Septal Occluder Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Atrial Septal Occluder Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Atrial Septal Occluder Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Atrial Septal Occluder Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Atrial Septal Occluder Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Atrial Septal Occluder Sales Volume (%), (2019-2030)
    Figure 38. United States Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Atrial Septal Occluder Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Atrial Septal Occluder Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Atrial Septal Occluder Sales Value by Application (%), 2023 VS 2030
    Figure 59. Atrial Septal Occluder Industrial Chain
    Figure 60. Atrial Septal Occluder Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart